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ing patients with rare diseases, and studying attitudes and behaviours relating to 
taboo subjects. SM may also increase recruitment into research studies, especially 
from hard-to-reach groups.
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Objectives: Education in pharmacoeconomics is one of the primary goals of ISPOR. 
This study is aiming to explore the needs for pharmacoeconomic educations by 
national chapter among different pharmaceutical stakeholders. MethOds: Inquiry 
research was performed among the participants in 2 educational initiatives of the 
Bulgarian ISPOR chapter. In both seminars attended representatives of payers - 
Bulgarian government (MoH, NHIF), as well as from pharmaceutical business, non- 
governmental organizations and academia. On total 48 individuals left feedback from 
over 60 participants in both seminars. The questionnaires focused on the topics cov-
ered in the seminars, organizational matters and needs of new educational themes. 
Preferred themes were assessed and results are consolidated Results: Both semi-
nars target the same groups of individuals – institutions, academia, pharmaceutical 
business, and non-governmental organizations. The first seminar was focused mainly 
on the pricing and reimbursement of the pharmaceuticals with international lectur-
ers, while the second one covered basic pharmacoeconomic methods with national 
lectures. The overall satisfaction score from both seminars was very high (25%) and 
excellent (55%). The most preferred topic was the pricing and reimbursement of phar-
maceuticals by 53%, followed by different modeling techniques (47%). Participants 
wanted to know more about the way of regulatory usage of pharmacoeconomics in 
pricing and reimbursement (70%). Focus groups discussion (98%) and practical of 
pharmacoeconomic were also a matter of high preference (30%). cOnclusiOns: This 
study proves the necessity for education in the field of pharmacoeconomic, modeling, 
core models explanations and pharmaceuticals assessment. They also pointed out 
the place of national chapters as providers of education and independent organizers 
able to gather different stakeholders’ point of view in non-formal discussions. Having 
in mind that BG is in the beginning of the HTA process obviously willingness to be 
educated among the whole Pharma environment is definitely high.
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Objectives: In order to examine the current situation related to education in the 
field of pharmacoeconomics and Health-economics, we investigate which uni-
versities and colleges provide such training. The study included pharmaceutical, 
medical and dentistry faculties and departments as well as the health care col-
leges. Information on health care colleges and faculties in B&H are taken from State 
register of accredited higher education institutions. MethOds: We have analyzed 
the on-line availability of the curricula at official websites of health care faculties, 
its content for each program of study at the undergraduate and postgraduate level. 
All programs are qualitatively analyzed in terms if they include pharmacoeco-
nomics/health economics as a separate subject (mandatory or elective) Results: 
Twenty-two high health care institutions are identified; 5 medical, 4 dentistry, 9 
pharmaceutical faculties, 13 nursing and 6 othe. Seventeen of them have on-line 
available curricula, 3 are not available and 2 faculties do not have available web-
sites, so we included 77,7% of all health care faculties program. In undergraduate 
courses pharmacoeconomics/health-economics is included in curricula at 5 facul-
ties. Pharmacoeconomics as separate mandatory subject is included in curricula 
at 1 medical and 1 pharmacy faculty while at 3 health care colleges this area is 
covered through health-economics or health-management courses. In postgraduate 
programs (master and doctoral studies) just 3 faculties included health economics 
in its curricula; 1 medical faculty as mandatory subject, and 2 medical colleges 
as elective subject. cOnclusiOns: Pharmacoeconomic education for health care 
students in Bosnia and Herzegovina is poorly organized and not satisfactory. There 
is growing need to educate health care professional and stakeholders in this field to 
ensure proper understanding and implementation in practice and decision-making 
process. Limitation of this study is that detail programs and structure of courses 
could not be examined since it is not on-line available. Further research is recom-
mended to get deep insight into curricula.
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Objectives: To validate an innovative experience that aims at being recognized 
by Institutions as a national and independent HTA assessor, thus supporting both 
national and regional health care decison makers. This experience consists of 
a multi-stakeholder working group that, in the field of new technologies pro-
posed for critical clinical areas, discusses and develops guide-lines and decision 
rules and comparatively examines local data. MethOds: The working method 
consists of a series of meetings (4 per year) of a scientific board (composed 
by high-profile experts covering all HTA domains) that carries out a nationwide 
analysis of the topic under examination and focuses on the main clinical, eco-
nomic, organizational, social, and ethical aspects. Questionnaire-based surveys 
and Delphi panel are the main operational tools. WEF adopts standard HTA pro-
17.4% of all abstracts were in the Alergy diseases area. It was followed by Multiple 
Diseases (14%). cOnclusiOns: It was shown that the policy changing in 2008 as 
to require pharmacoeconomics dossiers in the reimbursement application effected 
Turkey specific pharmacoeconomic and health outcome studies positively. In other 
words, pharmaceutical ýndustry and the government started to invest in pharma-
coeconomics and health outcome studies after 2008.
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Objectives: To provide a long term analysis of the Hungarian hospital bed capaci-
ties. MethOds: During the preparation we performed bibliographic review includ-
ing research of related statistical data collections, historical hospital works. Data 
were derived from the database of the Hungarian Central Statistical Office and 
from historical documents. The study covered the period between 1800-2010. The 
following indicators were used: number of hospitals and hospital beds. Results: 
The first data available for hospital statistics dates back to 1800 and showed that 
there were 34 hospitals and 1590 hospital beds in Hungary. For 1867 the number of 
hospitals and hospital beds increased up to 46 and 4684 respectively. Shortly after 
the introduction of compulsory health insurance in 1891, the number of hospitals 
was 344 and the number of hospital beds was 16497 in 1895. After the First World 
War hospital number decreased to 183, and bed number increased to 26451. Since 
1945 to 1990 the number of hospitals varied between 147-287, while the number 
of hospital beds continuously increased from 33162 to 105097. After the social and 
political changes in 1990, hospital bed number showed strong decrease to 71216 in 
2010 with varying number of hospitals between 148-174. As a consequence in the 
changes of numbers of hospitals and hospital beds, the average bed number per 
one hospital continuously increased from 47 in 1800, 107 in 1915, 182 in 1950 and 
710 in 1990. cOnclusiOns: The definition and function of hospitals significantly 
changed during the past 200 years in Hungary. The former old fashioned small poor 
houses of the early 19th century have been replaced by hospitals with large number 
of hospital beds by 1990. After social and political changes in 1990, the number of 
hospitals beds in Hungary decreased and got closer to EU average.
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bAckgROund: With the evolution from data on paper into electronically available 
data, the term Big Data has made its entrance. This term is widely used and refers 
to the four V’s: Volume, Velocity, Variety and Veracity. Big Data is being used in many 
sectors such as retail and banking, and also in the health care sector. However, within 
the health care sector, this term is ill defined. Objectives: The main purpose of this 
study is to get an understanding of the definition of Big Data in health care. Further, 
it’s value and challenges will be explored. MethOds: : First, an attempt has been 
made to clarify the term Big Data in health care using the term “Big Data” in combina-
tion with ‘health’ in PubMed searches. Also, the internet and social media have been 
searched for definitions of Big Data in health care. Further, the potential use of Big 
Data in health care has been reviewed using these sources. Results: In the medical 
literature, the term Big Data is rarely used in health care research and no standard 
definitions of Big Data big data are available. The term is used in combination with 
electronic health care records (EHR), claims data, registries, pharmacy utilization 
records, and linkages between these databases. On the internet and social media, 
various definitions for Big Data in the health care sector can be found.” Values are: 
increased medical knowledge, improved quality of care, improved personalized medi-
cine, better health outcome prediction, and lower costs. Challenges with Big Data in 
Healthcare are of technical (different data structures), ethical (patient privacy) and 
scientific (quality issues, biases, causality assessment) magnitude. cOnclusiOns: 
Healthcare Big Data has poorly been defined. Use of Big Data can be beneficial in terms 
of better care and lower costs despite the challenges to be faced.
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Objectives: To assess the range and focus of health research that has involved 
interactive internet and mobile technology (“social media”; SM). MethOds: We 
conducted a systematic review of studies that investigated the use of SM, or used 
SM as a research tool, published in English since 2003 and indexed in MEDLINE 
and EMBASE. Results: We identified 3,773 unique studies, of which 304 reported 
primary research or were systematic reviews of such studies. Of these, 192 (63%) 
were surveys of actual or potential users of SM, including health care professionals 
(20%), patients with a specific disease or problem (46%), or the general public (34%); 
40 (13%) were articles describing SM tools or sites; 71 (23%) assessed the potential 
of SM to increase knowledge or improve clinical outcomes, of which 22 compared 
SM with more traditional support or information; 71 (23%) described SM users; 
53 (17%) sought their views on the benefits of SM; 24 (8%) discussed the potential 
harm its use could do to professional-patient relationships; and 25 (8%) analysed 
SM content. SM were also used as a tool to recruit participants into research (85 
articles, 28%), especially on topics such as sexual practices, intimate partner vio-
lence, or substance abuse, or involving groups typically underrepresented in clinical 
research. Of the various types of SM studied or used to recruit participants into 
research, Facebook was cited in 73 articles (24%); mobile apps in 40 papers (13%); 
PatientsLikeMe and Twitter in 13 articles (4%) each; MySpace in 3 articles (1%); and 
other online forums in 70 articles (23%). cOnclusiOns: SM is a rich source of data 
on patients and health care professionals. It may be particularly useful in target-
